The authors sought to alter transcriptional programs by enforcing expression of the catalytic domain of the methylcytosine dioxygenase TET2 in breast cancer cells.
[Life Science Alliance]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Mammary Cell News TET2-Mediated Epigenetic Reprogramming of Breast Cancer Cells Impairs Lysosome Biogenesis
